Vaccine and Infectious Disease Division

Scientist with petri dish

Featured News from VIDD

Dr. Larry Corey

Dr. Larry Corey

Fred Hutch News Service

A new path to an AIDS vaccine?

Called the AMP study, a ‘landmark,’ multinational clinical trial launched today to test HIV-blocking broadly neutralizing antibodies. VIDD Member Dr. Larry Corey, right, is one of two top HIV researchers chairing the trial.  Read more >

More Featured News from VIDD >

Upcoming VIDD Events

Chetan Seshadri, MD
Tuesday, May 3

Steve Pergam, MD, MPH
Tuesday, May 10
Pelton Auditorium

VIDD Faculty Stories

Understanding anti-viral immunity with Jenny Lund
The immune response to pathogens must be powerful enough to clear the infection but controlled enough to limit the scope of damage. Because an overactive response can result in autoimmune disease or organ transplant rejection, a fine balance is needed to maintain immune system homeostasis.

More VIDD Faculty Stories >

VIDD Publication Spotlight

Cytomegalovirus viral load predicts post-HSCT mortality
After undergoing hematopoietic stem cell transplantation (HSCT), patients are severely immunocompromised. This makes them susceptible to infections that do not normally cause disease in healthy individuals, such as cytomegalovirus (CMV).

More VIDD News >

Find VIDD Faculty

International Spotlight

Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.

More International Programs >>

VIDD Announcements

VIDD highlights promotions, new hires, honors/awards and goings of its faculty and staff.